A detailed history of Apg Asset Management N.V. transactions in Incyte Corp stock. As of the latest transaction made, Apg Asset Management N.V. holds 1,163,721 shares of INCY stock, worth $68.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,163,721
Previous 1,068,202 8.94%
Holding current value
$68.7 Million
Previous $67.1 Million 1.16%
% of portfolio
0.11%
Previous 0.12%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $5.4 Million - $6.36 Million
95,519 Added 8.94%
1,163,721 $66.3 Million
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $1.24 Million - $1.53 Million
23,836 Added 2.28%
1,068,202 $67.1 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $12 Million - $13.7 Million
207,560 Added 24.8%
1,044,366 $60.3 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $5.33 Million - $6.6 Million
-87,369 Reduced 9.45%
836,806 $52.1 Million
Q1 2023

May 12, 2023

SELL
$70.23 - $86.01 $26.1 Million - $31.9 Million
-370,960 Reduced 28.64%
924,175 $66.8 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $10.3 Million - $12.9 Million
152,883 Added 13.38%
1,295,135 $104 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $26.3 Million - $32.9 Million
-397,066 Reduced 25.79%
1,142,252 $77.7 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $30.2 Million - $37.9 Million
455,618 Added 42.04%
1,539,318 $112 Million
Q1 2022

May 12, 2022

SELL
$66.02 - $79.71 $475,344 - $573,912
-7,200 Reduced 0.66%
1,083,700 $77.4 Million
Q4 2021

Feb 11, 2022

BUY
$63.34 - $74.11 $14.1 Million - $16.5 Million
222,800 Added 25.67%
1,090,900 $70.4 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $1.12 Million - $1.37 Million
16,300 Added 1.91%
868,100 $51.5 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $37.3 Million - $40.9 Million
466,863 Added 121.28%
851,800 $60.4 Million
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $905,930 - $1.2 Million
-11,917 Reduced 3.0%
384,937 $26.6 Million
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $13.3 Million - $16.1 Million
164,869 Added 71.07%
396,854 $28.2 Million
Q3 2020

Nov 12, 2020

SELL
$85.07 - $109.69 $952,783 - $1.23 Million
-11,200 Reduced 4.61%
231,985 $17.8 Million
Q2 2020

Aug 14, 2020

BUY
$74.18 - $108.93 $8.77 Million - $12.9 Million
118,202 Added 94.57%
243,185 $22.5 Million
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $4.96 Million - $6.76 Million
78,575 Added 169.31%
124,983 $9.15 Million
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $53.6 Million - $72.9 Million
-848,303 Reduced 94.81%
46,408 $3.56 Million
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $8.3 Million - $10.9 Million
113,670 Added 14.55%
894,711 $69.6 Million
Q3 2019

Nov 08, 2019

BUY
$72.82 - $86.52 $48.8 Million - $58 Million
670,033 Added 603.59%
781,041 $53.2 Million
Q2 2019

Aug 13, 2019

BUY
$73.52 - $88.7 $4.75 Million - $5.73 Million
64,600 Added 139.2%
111,008 $8.28 Million
Q4 2018

Feb 13, 2019

BUY
$58.5 - $69.94 $87,750 - $104,910
1,500 Added 3.34%
46,408 $2.58 Million
Q2 2018

Aug 13, 2018

BUY
$60.85 - $83.98 $115,615 - $159,562
1,900 Added 4.42%
44,908 $2.58 Million
Q4 2017

Jan 24, 2018

SELL
$93.56 - $116.6 $1.21 Million - $1.51 Million
-12,948 Reduced 23.14%
43,008 $3.39 Million
Q3 2017

Oct 19, 2017

BUY
$109.15 - $138.27 $6.11 Million - $7.74 Million
55,956
55,956 $6.53 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.